CSIMarket
 
Xeris Biopharma Holdings Inc   (NASDAQ: XERS)
 

Xeris Biopharma Holdings Inc's Suppliers Performance

XERS's Supply Chain




 
XERS Costs vs Sales of Suppliers Growth Xeris Biopharma Holdings Inc recorded an increase in cost of sales by 5.16 % year on year, sequentially cost of sales grew by 18.33 % in Q2.

• More on XERS Suppliers



Xeris Biopharma Holdings Inc recorded increase in cost of sales by 5.16 % year on year, sequentially cost of sales grew by 18.33 % in Q2.

• More on XERS Suppliers




Xeris Biopharma Holdings Inc's Comment on Supply Chain









XERS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Xeris Biopharma Holdings Inc 1,572.69 335.41 24.02 65
SUBTOTAL 0.00 0.00 0.00 -


Sources: Xeris Biopharma Holdings Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Xeris Biopharma Holdings Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.